Bromodomain and extraterminal proteins regulate PD-L1/PD-1 signaling in breast cancer.

被引：0
|
作者：
Andrieu, Guillaume [1 ]
Denis, Gerald V. [1 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2018年 / 6卷 / 09期
关键词：
D O I：
10.1158/2326-6074.TUMIMM17-A17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A17
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [2] PD-1/PD-L1 Pathway in Breast Cancer
    Schuetz, Florian
    Stefanovic, Stefan
    Mayer, Luisa
    von Au, Alexandra
    Domschke, Christoph
    Sohn, Christof
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (05) : 294 - 297
  • [3] Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
    Ai, Luoyan
    Xu, Antao
    Xu, Jie
    REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 : 33 - 59
  • [4] The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
    Setordzi, Patience
    Chang, Xing
    Liu, Zi
    Wu, Yingliang
    Zuo, Daiying
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 895
  • [5] PD-L1/PD-1 blockade in breast cancer: The immunotherapy era
    Li, Chia-Jung
    Lin, Li-Te
    Hou, Ming-Feng
    Chu, Pei-Yi
    ONCOLOGY REPORTS, 2021, 45 (01) : 5 - 12
  • [6] Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
    Bertucci, Francois
    Goncalves, Anthony
    CURRENT ONCOLOGY REPORTS, 2017, 19 (10)
  • [7] Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
    François Bertucci
    Anthony Gonçalves
    Current Oncology Reports, 2017, 19
  • [8] PD-1 and PD-L1 Expression in Indian Women with Breast Cancer
    Bharadwa, Kishan R.
    Dasgupta, Kuheli
    Narayana, Suma Mysore
    Ramachandra, C.
    Babu, Suresh M. C.
    Rangarajan, Annapoorni
    Kumar, Rekha, V
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (01) : 21 - 29
  • [9] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
  • [10] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Linhares, Annika De Sousa
    Battin, Claire
    Jutz, Sabrina
    Leitner, Judith
    Hafner, Christine
    Tobias, Joshua
    Wiedermann, Ursula
    Kundi, Michael
    Zlabinger, Gerhard J.
    Grabmeier-Pfistershammer, Katharina
    Steinberger, Peter
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345